Results 11 to 20 of about 3,106,214 (162)

Anti-NMDA-receptor antibody encephalitis in infants [PDF]

open access: yesEpilepsy and Behavior Case Reports, 2015
Purpose: Anti-N-methyl-d-aspartate (NMDA) receptor antibody encephalitis is an autoimmune disorder manifesting subacutely with prominent aberrant movements and psychiatric symptoms.
Amr A. Matoq   +5 more
doaj   +2 more sources

Teratoma-negative anti-NMDA receptor encephalitis presenting with a single generalized tonic–clonic seizure

open access: yesEpilepsy and Behavior Case Reports, 2018
Herein, we describe a case report of anti-NMDA receptor encephalitis characterized by a single generalized tonic–clonic seizure and predominantly psychiatric symptoms, persisting long after EEG abnormalities had resolved.
Andy Cheuk-Him Ng   +2 more
doaj   +2 more sources

Psychiatric Presentation of Anti-NMDA Receptor Encephalitis

open access: yesFrontiers in Neurology, 2019
Background: Anti-N-methyl D-aspartate (NMDA) receptor encephalitis is an autoimmune condition characterized by neuropsychiatric symptoms, including epileptic seizures, movement disorders, autonomic instability, disturbances of consciousness, paranoia ...
Dominique Endres   +22 more
doaj   +2 more sources

Anti-N-Methyl-d-Aspartate Receptor Encephalitis

open access: yesPediatrics and Neonatology, 2011
Anti-N-methyl-d-aspartate (NMDA) receptor encephalitis is a treatment-responsive encephalitis associated with anti-NMDA receptor antibodies, which bind to the NR1/NR2 heteromers of the NMDA receptors.
Te-Yu Hung, Ning-Hui Foo, Ming-Chi Lai
doaj   +2 more sources

Long-Term Outcome of Pediatric Patients with Anti-NMDA Receptor Encephalitis in a Single Center

open access: yesChildren, 2023
Background: Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis is the most common autoimmune encephalitis in children. There is a high probability of recovery if treated promptly.
Pei-Yu Wu   +4 more
doaj   +2 more sources

Anti-N-methyl-D-aspartate receptor encephalitis mimics neuroleptic malignant syndrome: case report and literature review

open access: yesNeuropsychiatric Disease and Treatment, 2019
Hai-Yang Wang,1 Tian Li,2,3 Xue-Lin Li,4 Xiao-Xia Zhang,1 Zhong-Rui Yan,1 Yang Xu1 1Department of Neurology, Jining No 1 People’s Hospital, Jining, Shandong Province, People’s Republic of China; 2Department of Cardiology, Jining No 1 ...
Wang HY   +5 more
doaj   +1 more source

Pediatric anti-NMDA receptor encephalitis with catatonia: treatment with electroconvulsive therapy

open access: yesPediatric Rheumatology Online Journal, 2019
Background Anti-NMDA receptor encephalitis, an autoimmune disease associated with antibodies against N-methyl-D-aspartate (NMDA) receptors, is being diagnosed more frequently, especially in children and young adults.
Taha Moussa   +5 more
doaj   +2 more sources

Immunotherapy for anti-NMDA receptor encephalitis: Experience from a single center in Taiwan

open access: yesPediatrics and Neonatology, 2019
Background: Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis is an anti-neuronal antibody-mediated inflammatory brain disease that causes severe psychiatric and neurological deficits in previously healthy patients.
Shu-Sing Kong   +11 more
doaj   +2 more sources

Case report: meningitis as a presenting feature of anti-NMDA receptor encephalitis [PDF]

open access: yesBMC Infectious Diseases, 2020
Background Meningitis is a very rare atypical presenting feature of anti-NMDA receptor encephalitis. In our case report, we describe an unusual clinical presentation of anti-NMDA receptor encephalitis with a biphasic pattern of meningitis followed by ...
Maria Stavrou   +5 more
doaj   +2 more sources

Ofatumumab Therapy and Long-Term Seizure Outcomes of Patients With Relapsing Anti-NMDA Receptor Encephalitis. [PDF]

open access: yesAnn Clin Transl Neurol
ABSTRACT Objective There is a lack of studies on seizure outcomes associated with ofatumumab therapy in patients for relapsing anti‐N‐methyl‐D‐aspartate (NMDA) receptor encephalitis. We aimed to evaluate long‐term seizure outcomes of ofatumumab therapy for relapsing anti‐NMDA receptor encephalitis.
Wang J, Li M, Kong P.
europepmc   +2 more sources

Home - About - Disclaimer - Privacy